Structure is beauty, but not always truth.

ABSTRACT

Structural biology, as powerful as it is, can be misleading. We highlight four fundamental challenges interpreting raw experimental data; accounting for motion; addressing the misleading nature of in vitro structures; and unraveling interactions between drugs and "anti-targets." Overcoming these challenges will amplify the impact of structural biology on drug discovery.